ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2024
[Analysis of clinical characteristics of persistent HBeAg positivity in patients with chronic hepatitis B treated with nucleos(t)ide analogues].
L P Peng, W Q Gan, Y B Zheng, Y M Chen, J Liu, Z B Wu, Z L Gao
Abstract readEnglish Abstract
In one paragraphArticle in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
L P PengDepartment of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-sen; University Guangdong Key Laboratory of Liver Disease Research; Key Laboratory of Tropical Disease Control Research, Ministry of Education, Guangzhou 510630, China.
W Q GanDepartment of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-sen; University Guangdong Key Laboratory of Liver Disease Research; Key Laboratory of Tropical Disease Control Research, Ministry of Education, Guangzhou 510630, China.
Y B ZhengDepartment of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-sen; University Guangdong Key Laboratory of Liver Disease Research; Key Laboratory of Tropical Disease Control Research, Ministry of Education, Guangzhou 510630, China.
Y M ChenDepartment of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-sen; University Guangdong Key Laboratory of Liver Disease Research; Key Laboratory of Tropical Disease Control Research, Ministry of Education, Guangzhou 510630, China.
J LiuDepartment of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-sen; University Guangdong Key Laboratory of Liver Disease Research; Key Laboratory of Tropical Disease Control Research, Ministry of Education, Guangzhou 510630, China.
Z B WuDepartment of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-sen; University Guangdong Key Laboratory of Liver Disease Research; Key Laboratory of Tropical Disease Control Research, Ministry of Education, Guangzhou 510630, China.
Z L GaoDepartment of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-sen; University Guangdong Key Laboratory of Liver Disease Research; Key Laboratory of Tropical Disease Control Research, Ministry of Education, Guangzhou 510630, China.
Funding
National Natural Science Foundation of China 82170612, 81672701Prominent National Science and Technology Initiatives 2018ZX10302204-002
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Hepatitis BHepatitis B, ChronicAntiviral AgentsDNA, ViralFemaleHepatitis B e AntigensHepatitis B Surface AntigensHepatitis B virusHumansLiver CirrhosisNeoplasm Recurrence, LocalRetrospective StudiesTreatment OutcomeAntiviral AgentsDNA, ViralHepatitis B e AntigensHepatitis B Surface AntigensChronic hepatitis BFamily historyFeature
Identifiers
PMID38584099
PMCPMC12814188
What OpenQuestion holds
Textmetadata
Read underepoch 390